New Report Analyzes Pharmaceutical Sales Training PR Newswire via Yahoo! Finance
Pharmaceutical business intelligence leader Cutting Edge Information announces the launch of a new report, "Pharmaceutical Sales Training Groups: Building Better Sales Forces" .
Teva Q3 profit up on generic sales, IVAX Reuters via Yahoo! News
Teva Pharmaceutical Industries Ltd. said third-quarter earnings rose on strong sales of generic versions of blockbuster treatments for depression and cholesterol, as well as its recent acquisition of
StayinFront to Exhibit at the eyeforpharma 4th Annual Pharmaceutical Conference SYS-CON Media
WHO: StayinFront, Inc., a leading global provider of enterprise-wide customer relationship management (CRM) applications, decision support tools, data services, sample inventory management solutions and eBusiness systems WHAT: StayinFront is exhibiting the company's award-winning suite of solutions at the upcoming eyeforpharma 4th Annual Pharmaceutical Conference, Sales Force Effectiveness USA
Teva 3Q Profit Soars on Sales Boost AP via Yahoo! Finance
Generic drug maker Teva Pharmaceuticals Industries Ltd. said Tuesday its third-quarter profit more than doubled on sales from 22 new products and contributions from Ivax products.
Takeda reports record interim sales Japan Today
TOKYO — Takeda Pharmaceutical Co said Monday it has posted record-high group sales and raised the dividend payout for the first half of fiscal 2006, thanks to robust sales of ethical drugs and the yen's depreciation against both the U.S. dollar and the euro.
La Jolla Pharmaceutical Announces Continued Progress With Phase 3 International RiquentR Study Medical News Today
La Jolla Pharmaceutical Company (Nasdaq: LJPC) today announced significant progress in enrolling patients and opening sites for its Phase 3 clinical trial of Riquent(R) (abetimus sodium) for the treatment of lupus renal disease. To date, 82 patients have been enrolled in the study, with 40 patients randomized in October. [click link for full article]
Ferring Pharmaceutical's Director of Medical Science Services Receives Family Building Award From The American PR Newswire via Yahoo! Finance
Paul Weathersbee, Ph.D., director of Ferring Pharmaceutical's Medical Science Services, received a "Family Building Award" last night at the American Fertility Association's annual benefit, The Kokopelli Ball, at Pier 60 at Chelsea Piers in New York City.
IMS Health forecasts 5-6 % growth for global pharmaceutical market in 2007 PharmaBiz
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, projected global pharmaceutical market growth of 5-6 per cent for 2007, compared with 6-7 per cent in 2006, as the market continues to rebalance in light of changing market dynamics.
AlphaRx Signs Feasibility and Option Agreement With a Global Specialty Pharmaceutical Company for Its Nanoparticle Drug Market Wire via Yahoo! Finance
AlphaRx Inc. announces the signing of a Feasibility and Option Agreement with a global pharmaceutical company based in the U.S. Under the terms of the Agreement, AlphaRx will use its proprietary nanoparticle drug delivery platforms to formulate three products to enhance their effectiveness in treating pre-defined disease indications and of the three products, two are marketed products.
Astellas ups outlook, yen offsets weak Japan sales Reuters via Yahoo! Asia News
TOKYO, Nov 7 (Reuters) - Astellas Pharma Inc. , Japan's third-biggest drug maker, nudged up its annual sales and pretax profit outlook on Tuesday, as favourable exchange rates offset weak sales in its home market.